Effects of counseling Ashkenazi jewish women about breast cancer risk

Cultural Diversity and Ethnic Minority Psychology

Volumn 12, Issue 1, 2006, Pages 45-56

  Bowen, Deborah J ^a,d   Burke, Wylie ^a   Culver, Julie O ^b   Press, Nancy ^c   Crystal, Susan ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b University of Washington ^*

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Ashkenazi Jewish; Breast cancer risk counseling; Genetic counseling; Genetic testing

Indexed keywords

ADULT; ANXIETY; ARTICLE; ASHKENAZI JEW; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC COUNSELING; GENETIC PROCEDURES; HUMAN; JEW; MAJOR CLINICAL STUDY; PATIENT COUNSELING; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELIGIOUS GROUP; RISK BENEFIT ANALYSIS; SOCIAL PSYCHOLOGY; BREAST TUMOR; COUNSELING; DEMOGRAPHY; ETHNOLOGY; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR; RISK REDUCTION;

ADULT; BREAST NEOPLASMS; COUNSELING; DEMOGRAPHY; FEMALE; GENETIC COUNSELING; HUMANS; JEWS; MIDDLE AGED; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 33744522665     PISSN: 10999809     EISSN: None     Source Type: Journal    
DOI: 10.1037/1099-9809.12.1.45     Document Type: Article

References (37)

1. American College of Medical Genetics. (1996). Statement on population screening for BRCA-1 mutation in Ashkenazi Jewish women. Retrieved December 5, 2002, from http://www.acmg. net/resources/policies/pol-002.asp
2. Andersen, M. R., Bowen, D., McTiernan, A., & Yasui, Y. (2002). Awareness and concern about ovarian cancer among women at risk due to a family history of breast or ovarian cancer. Clinical Journal of Women's Health, 2(1), 5-12.
3. Andrykowski, M. A., Lightner, R., Studts, J., & Munn, R. K. (1997). Hereditary cancer risk notification and testing: How interested is the general population? Journal of Clinical Oncology, 15, 2139-2148.
4. Bowen, D. J., Burke, W., McTiernan, A., Powers, D., & Andersen, M. R. (2004). Breast cancer risk counseling improves women's functioning. Patient Education and Counseling, 53, 79-86.
5. Bowen, D. J., Burke, W., Yasui, Y., McTiernan, A., & McLeran, D. (2002). Effects of risk counseling on interest in breast cancer genetic testing for lower risk women. Genetics in Medicine, 4, 359-365.
6. Bowen, D. J., Christensen, C. L., Powers, D., Graves, D. R., & Anderson, C. A. M. (1998). Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. Journal of Clinical Psychology in Medical Settings, 5, 365-379.
7. Bowen, D. J., Singal, R., Eng, E., Crystal, S., & Burke, W. (2003). Jewish identity and intentions to obtain breast cancer screening. Cultural Diversity and Ethnic Minority Psychology, 9, 79-87.
8. Breast Cancer Linkage Consortium. (1999). Cancer risks in BRCA2 mutation carriers: The Breast Cancer Linkage Consortium. Journal of the National Cancer Institute, 91, 1310-1316.
9. Brose, M. S., Rebbeck, T. R., Calzone, K. A., Stopfer, J. E., Nathanson, K. L., & Weber, B. L. (2002). Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute, 94, 1365-1372.
10. Burke, W., & Austin, M. A. (2002). Genetic risk in context: Calculating the penetrance of BRCA1 and BRCA2 mutations. Journal of the National Cancer Institute, 94, 1185-1187.
11. Burke, W., Culver, J. O., Bowen, D., Lowry, D., Durfy, S., McTiernan, A., et al. (2000). Genetic counseling for women with an intermediate family history of breast cancer. American Journal of Medical Genetics, 90, 361-368.
12. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J. E., Lynch, P., et al. (1997). Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA 1 and BRCA 2. Journal of the American Medical Association, 277, 997-1003.
13. Claus, E., B., Risch, N., & Thompson, W. D. (1994). Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer, 73, 643-651.
14. Croyle, R. T., Achilles, J. S., & Lerman, C. (1997). Psychologic aspects of cancer genetic testing: A research update for clinicians. Cancer, 80(3, Suppl), 569-575.
15. Derogatis, L. R., & Melisaratos, N. (1983). The Brief Symptom Inventory: An introductory report. Psychological Medicine, 13, 595-605.
16. Durfy, S. J., Bowen, D. J., McTiernan, A., Sporleder, J., & Burke, W. (1999). Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiology, Biomarkers & Prevention, 8(4, Part 2), 369-375.
17. Ford, D., Easton, D. F., & Peto, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics, 57, 1457-1462.
18. Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., et al. (1989). Projecting individualized probabilities of developing breast cancer for White females who are being examined annually. Journal of the National Cancer Institute, 81, 1879-1886.
19. Grann, V. R., Whang, W., Jacobson, J. S., Heitjan, D. F., Antman, K. H., & Neugut, A. I. (1999). Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2. Journal of Clinical Oncology, 17, 494-500.
20. Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute, 93, 1633-1637.
21. Hudson, K. L., Rothenberg, K. H., Andrews, L. B., Kahn, M. J. E., & Collins, F. S. (1995). Genetic discrimination and health insurance: An urgent need for reform. Science, 270, 391-393.
22. Lerman, C., Peshkin, B. N., Hughes, C., & Isaacs, C. (1998). Family disclosure in genetic testing for cancer susceptibility: Determinants and consequences. Journal of Health Care Law & Policy, 1, 353-372.
23. Lerman, C., Trock, B., Rimer, B., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychology, 10, 259-267.
24. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
25. Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., et al. (1996). The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nature Genetics, 14, 188-190.
26. Phinney, J. S. (1992). The Multigroup Ethnic Identity Measure: A new scale for use with diverse groups. Journal of Adolescent Research, 7, 156-176.
27. Richards, C. S., Ward, P. A., Roa, B. B., Friedman, L. C., Boyd, A. A., Kuenzli, G., et al. (1997). Screening for 185delAG in the Ashkenazim. American Journal of Human Genetics, 60, 1085-1098.
28. Rothenberg, K. H. (1997). Breast cancer, the genetic "quick fix," and the Jewish community. Ethical, legal, and social challenges. Health Matrix: Journal of Law-Medicine, 7, 97-124.
29. Rothenberg, K., Fuller, B., Rothstein, M., Duster, T., Kahn, M. J. E., Cunningham, R., et al. (1997). Genetic information and the workplace: Legislative approaches and policy changes. Science, 275, 1755-1757.
30. Stolberg, S. G. (1998, April 22). Concern among Jews is heightened as scientists deepen gene studies. New York Times, p. A24.
31. Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., et al. (1995). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genetics, 11, 198-200.
32. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New England Journal of Medicine, 336, 1401-1408.
33. Tambor, E. S., Bernhardt, B. A., Chase, G. A., Faden, R. R., Geller, G., Hofman, K. J., et al. (1994). Offering cystic fibrosis carrier screening to an HMO population: Factors associated with utilization. American Journal of Human Genetics, 55, 626-637.
34. Tambor, E. S., Rimer, B. K., & Strigo, T. S. (1997). Genetic testing for breast cancer susceptibility: Awareness and interest among women in the general population. American Journal of Medical Genetics, 68, 43-49.
35. Ulrich, C. M., Kristal, A. R., White, E., Hunt, J. R., Durfy, S. J., & Potter, J. D. (1999). Genetic testing for cancer risk: A population survey of attitudes and intention. Community Genetics, 1, 213-222.
36. Weinstein, N. D. (1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10, 481-500.
37. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.